We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sharpless Addresses ‘Misunderstanding’ About Naloxone Dispensing
Sharpless Addresses ‘Misunderstanding’ About Naloxone Dispensing
Acting FDA Commissioner Ned Sharpless issued a statement on Friday on the agency’s efforts to increase the availability of naloxone — and to clear up confusion over how the injectable form of the opioid overdose drug can be dispensed.